Global Health Ltd vs Thyrocare Technologies Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Global Health Ltd is ₹ 1184 as of 23 Oct 15:30 . The P/E Ratio of Global Health Ltd changed from 43.3 on March 2023 to 46.4 on March 2026 . This represents a CAGR of 1.74% over 4 yearsThe P/E Ratio of Thyrocare Technologies Ltd changed from 42.2 on March 2021 to 34.2 on March 2026 . This represents a CAGR of -3.44% over 6 years The Market Cap of Global Health Ltd changed from ₹ 14111 crore on March 2023 to ₹ 25850 crore on March 2026 . This represents a CAGR of 16.34% over 4 yearsThe Market Cap of Thyrocare Technologies Ltd changed from ₹ 4774 crore on March 2021 to ₹ 5566 crore on March 2026 . This represents a CAGR of 2.59% over 6 years The revenue of Global Health Ltd for the Jun '26 is ₹ 1326 crore as compare to the Mar '26 revenue of ₹ 1195 crore. This represent the growth of 10.91% The revenue of Thyrocare Technologies Ltd for the Jun '26 is ₹ 244.88 crore as compare to the Mar '26 revenue of ₹ 228.84 crore. This represent the growth of 7.01% The ebitda of Global Health Ltd for the Jun '26 is ₹ 308.92 crore as compare to the Mar '26 ebitda of ₹ 280.51 crore. This represent the growth of 10.13% The ebitda of Thyrocare Technologies Ltd for the Jun '26 is ₹ 82.13 crore as compare to the Mar '26 ebitda of ₹ 79.98 crore. This represent the growth of 2.69% The net profit of Global Health Ltd changed from ₹ 106.26 crore to ₹ 157.25 crore over 9 quarters. This represents a CAGR of 19.03% The net profit of Thyrocare Technologies Ltd changed from ₹ 23.94 crore to ₹ 51.33 crore over 9 quarters. This represents a CAGR of 40.35% The Dividend Payout of Global Health Ltd changed from 2.71 % on March 2026 to 2.71 % on March 2026 . This represents a CAGR of 0.00% over 1 yearsThe Dividend Payout of Thyrocare Technologies Ltd changed from 110.36 % on March 2021 to 149.75 % on March 2026 . This represents a CAGR of 5.22% over 6 years .

About Global Health Ltd

Global Health Limited (GHL) was incorporated as Global Health Private Limited' on August 13, 2004 at New Delhi, India as a Private Company.
The status of the Company got converted into a Public Limited Company and the name was changed to Global Health Limited' dated August 11, 2021 issued by the RoC. Presently, the Company is engaged in providing healthcare services. The Company was founded by Dr. Naresh Trehan, a world-renowned cardiovascular and cardiothoracic surgeon.
The Company is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India in terms of bed capacity with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urologoly.

About Thyrocare Technologies Ltd

Thyrocare Technologies Limited was incorporated in January, 2000.
The Company operates in the healthcare industry and is involved in providing quality diagnostic services at affordable costs to patients, laboratories and hospitals in India. As of 31 March 2025, the Company offered more than 920 distinct tests that support early detection, preventive care and the ongoing disease monitoring.
Their 43 profiles are administered under its reputed 'Aarogyam' brand, which offers patients a suite of wellness and preventive health care tests.
The Company primarily operates its testing services through a fully automated Centralised Processing Laboratory (the CPL) and has expanded its operations to include a network of Regional Processing Laboratories (RPLs).
The company currently operates 25 RPLs, one in each of New Delhi, Coimbatore, Hyderabad, Kolkata, Bangalore, Bhopal, Mumbai Patna and Chennai, which process samples sourced from their respective regions.

FAQs for the comparison of Global Health Ltd and Thyrocare Technologies Ltd

Which company has a larger market capitalization, Global Health Ltd or Thyrocare Technologies Ltd?

Market cap of Global Health Ltd is 31,850 Cr while Market cap of Thyrocare Technologies Ltd is 7,357 Cr

What are the key factors driving the stock performance of Global Health Ltd and Thyrocare Technologies Ltd?

The stock performance of Global Health Ltd and Thyrocare Technologies Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Global Health Ltd and Thyrocare Technologies Ltd?

As of October 25, 2026, the Global Health Ltd stock price is INR ₹1184.6. On the other hand, Thyrocare Technologies Ltd stock price is INR ₹462.25.

How do dividend payouts of Global Health Ltd and Thyrocare Technologies Ltd compare?

To compare the dividend payouts of Global Health Ltd and Thyrocare Technologies Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.